Bank of Montreal’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-93
Closed -$13K 5012
2021
Q1
$13K Sell
93
-310
-77% -$50.4K ﹤0.01% 4247
2020
Q4
$72K Buy
403
+282
+233% +$50.1K ﹤0.01% 3761
2020
Q3
$21K Sell
121
-85
-41% -$17.1K ﹤0.01% 3822
2020
Q2
$43K Buy
+206
New +$42.4K ﹤0.01% 3501
2020
Q1
Sell
-217
Closed -$52K 4803
2019
Q4
$52K Buy
217
+66
+44% +$12.7K ﹤0.01% 3820
2019
Q3
$26K Buy
151
+41
+37% +$9.28K ﹤0.01% 3949
2019
Q2
$21K Buy
+110
New +$23.7K ﹤0.01% 4162
2019
Q1
Sell
-7
Closed -$1K 4809
2018
Q4
$1K Buy
7
+3
+75% +$914 ﹤0.01% 4572
2018
Q3
$2K Buy
+4
New +$1.77K ﹤0.01% 4407

Other funds holding TECX

Bank of Montreal's TECX Position: Q2 2021 in Review

Bank of Montreal sold out of Tectonic Therapeutic (TECX) in Q2 2021, closing a stake of 93 shares — an estimated $13K sold.

Bank of Montreal first reported a position in TECX in Q3 2018 and held it in 9 quarters. The position peaked at $72K in Q4 2020. 97 funds tracked by Wall St. Rank hold TECX as of Q2 2021.

  • Bank of Montreal reported no remaining Tectonic Therapeutic position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 93 Tectonic Therapeutic shares in Q2 2021, an estimated $13K.
  • Bank of Montreal first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 9 quarters.
  • Bank of Montreal's Tectonic Therapeutic position peaked at $72K in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.